Hudson, Wisconsin – Phillips-Medisize, a Molex company, broke ground last month for a new medical device manufacturing facility located in the St. Croix Meadows development in Hudson, Wisconsin. This site is expected to support at least 230,000ft2 of manufacturing space for FDA-regulated products. The facility is slated for completion in late 2019 to mid-2020.
“We are proud to invest in growing Phillips-Medisize’s manufacturing presence in our founding state of Wisconsin,” stated Matt Jennings, CEO and president, Phillips-Medisize. “Hudson has been home to Phillips-Medisize for the past 36 years, so we are excited to reinforce our commitment to the vibrant community with our St. Croix Meadows facility. We expect to support over 250 employment opportunities for area residents in jobs, ranging from skilled manufacturing to engineering. It also reaffirms our commitment to better serve customers as a global end-to-end provider of innovation, development and manufacturing solutions.”
Founded in the town of Phillips, Wisconsin over five decades ago, Phillips-Medisize currently employs more than 5,500 people at 26 manufacturing sites around the world. This new Phillips-Medisize facility will be situated on a 34-acre site in St. Croix Meadows development, representing the company’s single largest operation in Wisconsin with opportunity to expand.
The Phillips-Medisize St. Croix Meadows manufacturing facility will be FDA-registered, adhering to cleanroom practices, featuring equipment to meet medical device quality production standards.